These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32357614)

  • 1. Effects of somatostatin on somatotroph adenomas of the human pituitary: An in vitro functional and morphological study.
    Asa SL; Felix I; Kovacs K; Ramyar L
    Endocr Pathol; 1990 Dec; 1(4):228-235. PubMed ID: 32357614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of growth hormone-releasing hormone (GHRH) on densely granulated somatotroph adenomas and sparsely granulated somatotroph adenomas in vitro: a morphological and functional investigation.
    Kawakita S; Asa SL; Kovacs K
    J Endocrinol Invest; 1989; 12(7):443-48. PubMed ID: 2551950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and functional properties of densely and sparsely granulated GH-producing pituitary adenomas.
    Mayr B; Buslei R; Theodoropoulou M; Stalla GK; Buchfelder M; Schöfl C
    Eur J Endocrinol; 2013 Oct; 169(4):391-400. PubMed ID: 23847328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of SMS 201-995, a long-acting somatostatin analogue, on the secretion and morphology of a pituitary growth hormone cell adenoma.
    George SR; Kovacs K; Asa SL; Horvath E; Cross EG; Burrow GN
    Clin Endocrinol (Oxf); 1987 Apr; 26(4):395-405. PubMed ID: 2888549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of alpha-subunit of glycoprotein hormones by pituitary somatotroph adenomas in vitro.
    Kontogeorgos G; Asa SL; Kovacs K; Smyth HS; Singer W
    Acta Endocrinol (Copenh); 1993 Dec; 129(6):565-72. PubMed ID: 7509101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro short-term effects of SMS 201-995, bromocriptine and TRH on growth hormone cell morphology from human pituitary adenomas.
    García García J; Jiménez Reina L; García Luna PP; Leal Cerro A; Astorga Jiménez R; García García-Revillo J; Bernal Valls G
    Histol Histopathol; 1989 Apr; 4(2):223-33. PubMed ID: 2520459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human pituitary somatotroph adenoma and prolactinoma: an ultrastructural and immunoelectron microscopical study.
    Zhou XJ; Zhang TH; Yu YQ; Wang FA
    J Tongji Med Univ; 1990; 10(2):83-7. PubMed ID: 2213957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Octreotide Effect on Growth Hormone and Somatostatin Subtype 2 Receptor mRNAs of the Human Pituitary Somatotroph Adenomas.
    Stefaneanu L; Kovacs K; Thapar K; Horvath E; Melmed S; Greenman Y
    Endocr Pathol; 2000; 11(1):41-48. PubMed ID: 12114656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone (GH) and prolactin (PRL) gene expression and immunoreactivity in GH- and PRL-producing human pituitary adenomas.
    Li J; Stefaneanu L; Kovacs K; Horvath E; Smyth HS
    Virchows Arch A Pathol Anat Histopathol; 1993; 422(3):193-201. PubMed ID: 8493775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinicomorphological study of pituitary tumors associated with the clinical syndrome of acromegaly.
    Andreeva M; Georgiev T; Bosadjieva E; Karagiosov L; Karagiosov K; Tomova A; Matrosov P; Kirilov G; Diankov L; Christova T
    Exp Clin Endocrinol; 1991; 98(3):223-7. PubMed ID: 1778242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro studies of human pituitary adenomas.
    Asa SL
    Pathol Res Pract; 1988 Sep; 183(5):561-4. PubMed ID: 3237545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Definition and differential diagnosis of chromophobe pituitary adenomas: light and electron microscopic studies].
    Saeger W; Breuer H; Lüdecke D
    Beitr Pathol; 1976 May; 157(4):367-90. PubMed ID: 183657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathological analyses of silent pituitary somatotroph adenomas using immunohistochemistry, in situ hybridization and confocal laser scanning microscopic observation.
    Matsuno A; Itoh J; Itoh Y; Osamura RY; Katayama H; Nagashima T
    Pathol Res Pract; 2001; 197(1):13-20. PubMed ID: 11209812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A light and electron microscopical study of pituitary adenomas.
    Stefăneanu L; Taşcă C; Coculescu M
    Endocrinologie; 1981; 19(4):243-8. PubMed ID: 7323648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vasoactive intestinal polypeptide (VIP) on growth hormone (GH) and prolactin (PRL) release and cell morphology in human pituitary adenoma cell cultures.
    Fazekas I; Bácsy E; Varga I; Slowik F; Bálint K; Pásztor E; Czirják S; Gláz E
    Folia Histochem Cytobiol; 2000; 38(3):119-27. PubMed ID: 10970071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological effects of octreotide on growth hormone-producing pituitary adenomas.
    Ezzat S; Horvath E; Harris AG; Kovacs K
    J Clin Endocrinol Metab; 1994 Jul; 79(1):113-8. PubMed ID: 8027215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo responsiveness of morphological variants of growth hormone-producing pituitary adenomas to octreotide.
    Ezzat S; Kontogeorgos G; Redelmeier DA; Horvath E; Harris AG; Kovacs K
    Eur J Endocrinol; 1995 Dec; 133(6):686-90. PubMed ID: 8548053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function correlations of growth hormone or/and prolactin-producing pituitary adenomas: an in vitro study with the reverse hemolytic plaque assay.
    Thodou E; Kontogeorgos G; Kyrodimou E; Salla H; Ramyar L; Vamvassakis E; Piaditis G; Anagnostopoulos N; Tzanis S; Levedis A; Rologis D; Asa SL
    J Endocrinol Invest; 1999 Oct; 22(9):671-80. PubMed ID: 10595830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin Receptor Expression in GH-Secreting Pituitary Adenomas Treated with Long-Acting Somatostatin Analogues in Combination with Pegvisomant.
    Franck SE; Gatto F; van der Lely AJ; Janssen JAMJL; Dallenga AHG; Nagtegaal AP; Hofland LJ; Neggers SJCMM
    Neuroendocrinology; 2017; 105(1):44-53. PubMed ID: 27455094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.